Cover Image
市場調查報告書

卵巢疾病:全球臨床實驗檢討

Ovarian Disease Global Clinical Trials Review, H2, 2015

出版商 GlobalData 商品編碼 226831
出版日期 內容資訊 英文 128 Pages
訂單完成後即時交付
價格
Back to Top
卵巢疾病:全球臨床實驗檢討 Ovarian Disease Global Clinical Trials Review, H2, 2015
出版日期: 2015年12月04日 內容資訊: 英文 128 Pages
簡介

目錄

目錄 2

  • 表格一覽
  • 圖表一覽
  • 簡介
  • 卵巢疾病
  • 報告指南
  • 臨床實驗 各地區
  • 臨床實驗 各國
  • 對臨床實驗有所貢獻的前幾名國家 - 亞太地區
  • 對臨床實驗有所貢獻的前五國 - 歐洲
  • 對臨床實驗有所貢獻的前幾名國家 - 北美
  • 對臨床實驗有所貢獻的前五國 - 中東及非洲
  • 臨床實驗 ; 金磚四國 各國
  • 臨床實驗 ; G7 各國
  • 臨床實驗 - G7 各國 各臨床實驗狀態
  • 臨床實驗 ; E7 各國
  • 臨床實驗 - E7 各國 各臨床實驗狀態
  • 臨床實驗 各階段
  • 進行中的臨床實驗 各階段
  • 臨床實驗 各臨床實驗狀態
  • 未完成的臨床實驗; 卵巢疾病
  • 每段時期的實驗人數
  • 有力的贊助商
  • 前幾名參與企業 - 卵巢疾病 治療藥物的臨床實驗
  • 潛力治療藥物 比較
  • 臨床實驗簡介
  • 臨床實驗概要; 前幾名企業
  • Organon USA Inc.
  • 臨床實驗概要; Organon USA Inc.
  • Merck & Co., Inc.
  • 臨床實驗概要; Merck & Co., Inc.
  • Ferring Pharmaceuticals
  • 臨床實驗概要; Ferring Pharmaceuticals
  • Eugonia
  • 臨床實驗概要; Eugonia
  • Omrix Biopharmaceuticals, Inc.
  • 臨床實驗概要; Omrix Biopharmaceuticals, Inc.
  • 臨床實驗概要; 最高級大學 / 研究機關 / 醫院
  • Instituto Valenciano de Infertilidad
  • 臨床實驗概要; Instituto Valenciano de Infertilidad
  • Children's Memorial Hospital
  • 臨床實驗概要; Children's Memorial Hospital
  • Nemours Children's Clinic
  • 臨床實驗概要; Nemours Children's Clinic
  • Virginia Center for Reproductive Medicine
  • 臨床實驗概要; Virginia Center for Reproductive Medicine
  • King's College London
  • 臨床實驗概要; King's College London
  • Yale University
  • 臨床實驗概要; Yale University
  • Cairo University
  • 臨床實驗概要; Cairo University
  • University of Connecticut Health Center
  • 臨床實驗概要; University of Connecticut Health Center
  • Shahid Beheshti University
  • 臨床實驗概要; Shahid Beheshti University
  • Royan Institute
  • 臨床實驗概要; Royan Institute
  • University of Schleswig-Holstein
  • 臨床實驗概要; University of Schleswig-Holstein
  • Columbia University
  • 臨床實驗概要; Columbia University
  • The University of Edinburgh
  • 臨床實驗概要; The University of Edinburgh
  • Tabriz University
  • 臨床實驗概要; Tabriz University
  • UMC Utrecht
  • 臨床實驗概要; UMC Utrecht
  • Stanford University
  • 臨床實驗概要; Stanford University
  • Centers for Disease Control and Prevention
  • 臨床實驗概要; Centers for Disease Control and Prevention
  • Norwegian University of Science and Technology
  • 臨床實驗概要; Norwegian University of Science and Technology
  • Maastricht University Medical Center
  • 臨床實驗概要; Maastricht University Medical Center
  • Assistance Publique - Hopitaux de Paris
  • 臨床實驗概要; Assistance Publique - Hopitaux de Paris
  • 5件重要臨床簡介

附錄 81

  • 簡稱
  • 定義
  • 調查方法
  • 二級研究
  • 關於GlobalData
  • 諮詢方式
  • 免責聲明
  • 資訊來源

表格一覽

  • 卵巢疾病 全球治療藥物市場, 臨床實驗 各地區
  • 卵巢疾病 全球治療藥物市場, 臨床實驗 各國排名
  • 卵巢疾病 全球治療藥物市場, 進行中的臨床實驗 各國排名
  • 卵巢疾病 治療藥物的臨床實驗, 亞太地區,前幾名國家
  • 卵巢疾病 治療藥物的臨床實驗, 歐洲, 前五國
  • 卵巢疾病 治療藥物的臨床實驗, 北美, 前幾名國家
  • 卵巢疾病 治療藥物的臨床實驗, 中東及非洲, 前五國
  • 卵巢疾病 治療藥物的臨床實驗, 金磚四國 各國
  • 卵巢疾病 治療藥物的臨床實驗, G7 各國
  • 卵巢疾病 治療藥物市場, G7 各國, 臨床實驗 各臨床實驗狀態
  • 卵巢疾病 治療藥物的臨床實驗, E7 各國
  • 卵巢疾病 治療藥物市場, E7 各國, 臨床實驗 各臨床實驗狀態
  • 卵巢疾病 全球治療藥物市場, 臨床實驗 各階段
  • 卵巢疾病 全球治療藥物市場, 進行中的臨床實驗 各階段
  • 卵巢疾病 全球治療藥物市場, 臨床實驗 各臨床實驗狀態
  • 卵巢疾病 全球治療藥物市場, 一時中止的臨床實驗
  • 卵巢疾病 全球治療藥物市場, 終止的臨床實驗
  • 卵巢疾病 全球治療藥物臨床實驗, 平均登錄對象人數趨勢
  • 卵巢疾病 全球治療藥物臨床實驗, 主要的贊助商
  • 卵巢疾病 全球治療藥物臨床實驗, 前幾名企業 各階段
  • 卵巢疾病 全球治療藥物臨床實驗, 臨床實驗 ; 潛力治療藥物
  • 卵巢疾病 全球治療藥物臨床實驗市場, 臨床實驗 ; Organon USA Inc. 
  • 卵巢疾病 全球治療藥物臨床實驗市場, 臨床實驗 ; Merck & Co., Inc. 
  • 卵巢疾病 全球治療藥物臨床實驗市場, 臨床實驗 ; Ferring Pharmaceuticals
  • 卵巢疾病 全球治療藥物臨床實驗市場, 臨床實驗 ; Eugonia
  • 卵巢疾病 全球治療藥物臨床實驗市場, 臨床實驗 ; Omrix Biopharmaceuticals, Inc. 
  • 卵巢疾病 全球治療藥物臨床實驗市場, 臨床實驗 ; Instituto Valenciano de Infertilidad
  • 卵巢疾病 全球治療藥物臨床實驗市場, 臨床實驗 ; Children's Memorial Hospital
  • 卵巢疾病 全球治療藥物臨床實驗市場, 臨床實驗 ; Nemours Children's Clinic
  • 卵巢疾病 全球治療藥物臨床實驗市場, 臨床實驗 ; Virginia Center for Reproductive Medicine
  • 卵巢疾病 全球治療藥物臨床實驗市場, 臨床實驗 ; King's College London
  • 卵巢疾病 全球治療藥物臨床實驗市場, 臨床實驗 ; Yale University
  • 卵巢疾病 全球治療藥物臨床實驗市場, 臨床實驗 ; Cairo University
  • 卵巢疾病 全球治療藥物臨床實驗市場, 臨床實驗 ; University of Connecticut Health Center
  • 卵巢疾病 全球治療藥物臨床實驗市場, 臨床實驗 ; Shahid Beheshti University
  • 卵巢疾病 全球治療藥物臨床實驗市場, 臨床實驗 ; Royan Institute
  • 卵巢疾病 全球治療藥物臨床實驗市場, 臨床實驗 ; University of Schleswig-Holstein
  • 卵巢疾病 全球治療藥物臨床實驗市場, 臨床實驗 ; Columbia University
  • 卵巢疾病 全球治療藥物臨床實驗市場, 臨床實驗 ; The University of Edinburgh
  • 卵巢疾病 全球治療藥物臨床實驗市場, 臨床實驗 ; Tabriz University
  • 卵巢疾病 全球治療藥物臨床實驗市場, 臨床實驗 ; UMC Utrecht
  • 卵巢疾病 全球治療藥物臨床實驗市場, 臨床實驗 ; Stanford University
  • 卵巢疾病 全球治療藥物臨床實驗市場, 臨床實驗 ; Centers for Disease Control and Prevention
  • 卵巢疾病 全球治療藥物臨床實驗市場, 臨床實驗 ; Norwegian University of Science and Technology
  • 卵巢疾病 全球治療藥物臨床實驗市場, 臨床實驗 ; Maastricht University Medical Center
  • 卵巢疾病 全球治療藥物臨床實驗市場, 臨床實驗 ; Assistance Publique - Hopitaux de Paris

圖表一覽

  • 卵巢疾病 全球治療藥物市場, 臨床實驗 各地區 (%)
  • 卵巢疾病 全球治療藥物市場, 臨床實驗 各國排名
  • 卵巢疾病 全球治療藥物市場, 進行中的臨床實驗 各國排名
  • 卵巢疾病 治療藥物的臨床實驗, 亞太地區, 前幾名國家 (%)
  • 卵巢疾病 治療藥物的臨床實驗, 歐洲, 前五國 (%)
  • 卵巢疾病 治療藥物的臨床實驗, 中東及非洲, 前五國 (%)
  • 卵巢疾病 治療藥物的臨床實驗, G7 各國 (%)
  • 卵巢疾病 治療藥物市場, G7 各國, 臨床實驗 各臨床實驗狀態
  • 卵巢疾病 治療藥物市場, E7 各國, 臨床實驗 各臨床實驗狀態
  • 卵巢疾病 全球治療藥物市場, 臨床實驗 各階段 (%)
  • 卵巢疾病 全球治療藥物市場, 進行中的臨床實驗 各階段
  • 卵巢疾病 全球治療藥物市場, 臨床實驗 各臨床實驗狀態
  • 卵巢疾病 全球治療藥物臨床實驗, 平均登錄對象人數趨勢
  • 卵巢疾病 全球治療藥物臨床實驗, 主要的贊助商
  • 卵巢疾病 全球治療藥物臨床實驗, 前幾名企業 各階段
  • 卵巢疾病 全球治療藥物臨床實驗, 臨床實驗 ; 潛力治療藥物
  • GlobalData 調查方法

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3033CTIDB

GlobalData's clinical trial report, "Ovarian Disease Global Clinical Trials Review, H2, 2015" provides an overview of Ovarian Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Ovarian Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Ovarian Disease to Women's Health Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Ovarian Disease to Women's Health Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Ovarian Disease Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Ovarian Disease Therapeutics, Global, Clinical Trials by Region, 2015*
  • Ovarian Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Ovarian Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Ovarian Disease to Women's Health Clinical Trials, G7 Countries (%), 2015*
  • Ovarian Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Ovarian Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Ovarian Disease to Women's Health Clinical Trials, E7 Countries (%), 2015*
  • Ovarian Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Ovarian Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Ovarian Disease Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Ovarian Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Ovarian Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Ovarian Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*

List of Figures

  • Ovarian Disease Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Ovarian Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Ovarian Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Ovarian Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
  • Proportion of Ovarian Disease to Women's Health Clinical Trials, G7 Countries (%), 2015*
  • Ovarian Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Ovarian Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Ovarian Disease to Women's Health Clinical Trials, E7 Countries (%), 2015*
  • Ovarian Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Ovarian Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Ovarian Disease Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Ovarian Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Ovarian Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Ovarian Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Ovarian Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top